Vincent Paul Liptak, General Counsel at BlossomHill Therapeutics, Inc. (BLSM), bought 4,700 shares at $15.80 ($75K) on 2026-08-07, disclosed to the SEC on 2026-08-10.
General Counsel Vincent Paul Liptak purchased 2,500 shares for $39,500, marking the largest insider purchase in the company's history. This significant buy suggests the General Counsel sees strong value in the stock at current levels.
The stock is trading at $16.02, just 2.76% below its 52-week high of $16.475, indicating the stock is currently near its peak valuation.
Insider cluster: This is the largest insider purchase ever recorded for BlossomHill Therapeutics, Inc.; track this momentum.
Insufficient data — needs manual review
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.80 | 2,500 | $40K | 52.9% |
| 2 | $16.00 | 2,200 | $35K | 47.1% |
| Total | $15.89 avg | 4,700 | $75K | 100% |